| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1372929 | Bioorganic & Medicinal Chemistry Letters | 2011 | 4 Pages |
Abstract
AMPA receptors (AMPARs) are an increasingly important therapeutic target in the CNS. Aniracetam, the first identified potentiator of AMPARs, led to the rigid and more potent CX614. This lead molecule was optimized in order to increase affinity towards the AMPA receptor. The substitution of the dioxine with a benzoxazinone ring system increased the activity and allowed further investigation of the sidechain SAR.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Rudolf Mueller, Yong-Xin Li, Aidan Hampson, Sheng Zhong, Clayton Harris, Christopher Marrs, Stanislaw Rachwal, Jolanta Ulas, Lena Nielsson, Gary Rogers,